drugset / Trial / NCT00296686

Sequential Tranylcypromine (TC), TC + Dextroamphetamine and TC + Triiodothyronine for Refractory Depression

NCT00296686

Phase 4 Terminated 31 enrolled New York State Psychiatric Institute
NaSingle-groupOpen-labelTreatment

Summary

This pilot study will assess the efficacy of several sequential pharmacological treatments for patients with Refractory Depression.

Timeline

Start
2001-09
Primary completion
2006-08
Completion
2006-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Dextroamphetamine Small molecule 40 mg
Subject Liothyronine Small molecule 75 mg
Subject Tranylcypromine Small molecule 60 mg
Subject Tranylcypromine Small molecule 120 mg